Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats

Journal of Hypertension

Volumn 29, Issue 3, 2011, Pages 520-528

  Pacheco, Bruna Pm ^a   Crajoinas, Renato O ^a   Couto, Gisele K ^b   Davel, Ana Paula C ^b   Lessa, Lucília M ^b   Rossoni, Luciana V ^b   Girardi, Adriana C C ^a  

^a Santa Casa de Misericórdia de Vitória   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

hypertension; kidney; proximal tubule; sodium reabsorption

Indexed keywords

BICARBONATE; CHLORIDE ION; CREATININE; DIPEPTIDYL PEPTIDASE IV; LITHIUM ION; POTASSIUM ION; SITAGLIPTIN; SODIUM; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN 3;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BLOOD PH; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; ELECTROLYTE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; FLUID INTAKE; FOOD INTAKE; HEART RATE; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE VESICLE; MICROVILLUS; MICTURITION; NONHUMAN; PREHYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SODIUM URINE LEVEL; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WISTAR RAT;

EID: 79951677095     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328341939d     Document Type: Article

References (40)

1. Lambeir AM, Durinx C, Scharpe S, De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003; 40:209-294. (Pubitemid 36775376)
2. Marguet D, Bernard AM, Vivier I, Darmoul D, Naquet P, Pierres M. cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases. J Biol Chem 1992; 267:2200-2208.
3. Kenny AJ, Booth AG, George SG, Ingram J, Kershaw D, Wood EJ, et al. Dipeptidyl peptidase IV, a kidney brush-border serine peptidase. Biochem J 1976; 157:169-182.
4. Iwaki-Egawa S, Watanabe Y, Kikuya Y, Fujimoto Y. Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. J Biochem 1998; 124:428-433. (Pubitemid 28419692)
5. Hopsu-Havu VK, Glenner GG. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 1966; 7:197-201.
6. Pospisilik JA, Stafford SG, Demuth HU, Brownsey R, Parkhouse W, Finegood DT, et al. Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes 2002; 51:943-950. (Pubitemid 34438335)
7. Reimer MK, Holst JJ, Ahren B. Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. Eur J Endocrinol 2002; 146:717-727. (Pubitemid 34552507)
8. Ahren B, Simonsson E, Larsson H, Landin-Olsson M, Torgeirsson H, Jansson PA, et al. Inhibition of dipeptidyl peptidase IV improves metabolic control over a4-week study period intype 2diabetes. Diabetes Care 2002; 25:869-875. (Pubitemid 41094285)
9. Holst JJ, Deacon CF. Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. Diabetes 1998; 47:1663-1670. (Pubitemid 28476238)
10. Hirata K, Kume S, Araki S, Sakaguchi M, Chin-Kanasaki M, Isshiki K, et al. Exendin-4 has an antihypertensive effect in salt-sensitive mice model. Biochem Biophys Res Commun 2009; 380:44-49.
11. Laugero KD, Stonehouse AH, Guss S, Landry J, Vu C, Parkes DG. Exenatide improves hypertension in a rat model of the metabolic syndrome. Metab Syndr Relat Disord 2009; 7:327-334.
12. Okerson T, Yan P, Stonehouse A, Brodows R. Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes. Am J Hypertens 2009; 23:334-339.
13. Yu M, Moreno C, Hoagland KM, Dahly A, Ditter K, Mistry M, et al. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats. J Hypertens 2003; 21:1125-1135. (Pubitemid 36667866)
14. Carraro-Lacroix LR, Malnic G, Girardi AC. Regulation of Na\+/H\+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. Am J Physiol Renal Physiol 2009; 297:F1647-F1655.
15. Schultheis PJ, Clarke LL, Meneton P, Miller ML, Soleimani M, Gawenis LR, et al. Renal and intestinal absorptive defects in mice lacking the NHE3 Na\+/H\+ exchanger. Nat Genet 1998; 19:282-285. (Pubitemid 28309344)
16. Girardi AC, Degray BC, Nagy T, Biemesderfer D, Aronson PS. Association of Na(\+)-H(\+) exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule. J Biol Chem 2001; 276:46671-46677.
17. Girardi AC, Knauf F, Demuth HU, Aronson PS. Role of dipeptidyl peptidase IV in regulating activity of Na\+/H\+ exchanger isoform NHE3 in proximal tubule cells. Am J Physiol Cell Physiol 2004; 287:C1238-C1245. (Pubitemid 39382882)
18. Girardi AC, Fukuda LE, Rossoni LV, Malnic G, Reboucas NA. Dipeptidyl peptidase IV inhibition downregulates Na\+ - H\+ exchanger NHE3 in rat renal proximal tubule. Am J Physiol Renal Physiol 2008; 294:F414-F422. (Pubitemid 351199407)
19. Jackson EK, Dubinion JH, Mi Z. Effects of dipeptidyl peptidase IV inhibition on arterial blood pressure. Clin Exp Pharmacol Physiol 2008; 35:29-34. (Pubitemid 350197677)
20. Mistry GC, Maes AL, Lasseter KC, Davies MJ, Gottesdiener KM, Wagner JA, et al. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol 2008; 48:592-598. (Pubitemid 351503521)
21. Kocinsky HS, Girardi AC, Biemesderfer D, Nguyen T, Mentone S, Orlowski J, et al. Use of phospho-specific antibodies to determine the phosphorylation of endogenous Na\+/H\+ exchanger NHE3 at PKA consensus sites. Am J Physiol Renal Physiol 2005; 289:F249-F258. (Pubitemid 41003653)
22. Mahnensmith RL, Aronson PS. Interrelationships among quinidine, amiloride, and lithium as inhibitors of the renal Na\+-H\+ exchanger. J Biol Chem 1985; 260:12586-12592. (Pubitemid 16233462)
23. Schwark JR, Jansen HW, Lang HJ, Krick W, Burckhardt G, Hropot M. S3226, a novel inhibitor of Na\+/H\+ exchanger subtype 3 in various cell types. Pflugers Arch 1998; 436:797-800. (Pubitemid 28421380)
24. Crajoinas RO, Lessa LM, Carraro-Lacroix LR, Davel AP, Pacheco BP, Rossoni LV, et al. Posttranslational mechanisms associated with reduced NHE3 activity in adult vs. young prehypertensive SHR. Am J Physiol Renal Physiol 2010; 299:F872-F881.
25. Jackson EK, Mi Z. Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension. Hypertension 2008; 51:1637-1642.
26. Beierwaltes WH, Arendshorst WJ, Klemmer PJ. Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension 1982; 4:908-915. (Pubitemid 13176960)
27. Dilley JR, Stier CT Jr, Arendshorst WJ. Abnormalities in glomerular function in rats developing spontaneous hypertension. Am J Physiol 1984; 246 (1 Pt 2):F12-F20. (Pubitemid 14148466)
28. Doris PA. Renal proximal tubule sodium transport and genetic mechanisms of essential hypertension. J Hypertens 2000; 18:509-519. (Pubitemid 30303480)
29. LaPointe MS, Sodhi C, Sahai A, Batlle D. Na\+/H\+ exchange activity and NHE-3 expression in renal tubules from the spontaneously hypertensive rat. Kidney Int 2002; 62:157-165. (Pubitemid 34754058)
30. Woo AL, Noonan WT, Schultheis PJ, Neumann JC, Manning PA, Lorenz JN, et al. Renal function in NHE3-deficient mice with transgenic rescue of small intestinal absorptive defect. Am J Physiol Renal Physiol 2003; 284:F1190-1198. (Pubitemid 36578446)
31. Kim SW, Wang W, Kwon TH, Knepper MA, Frokiaer J, Nielsen S. Increased expression of ENaC subunits and increased apical targeting of AQP2 in the kidneys of spontaneously hypertensive rats. Am J Physiol Renal Physiol 2005; 289:F957-F968. (Pubitemid 41447050)
32. Guyton AC. Blood pressure control: special role of the kidneys and body fluids. Science 1991; 252:1813-1816. (Pubitemid 21917099)
33. Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension. Kidney Int Suppl 1996; 55:S35-S41.
34. Panico C, Luo Z, Damiano S, Artigiano F, Gill P, Welch WJ. Renal proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles of superoxide and Na\+/H\+ exchanger 3. Hypertension 2009; 54:1291-1297.
35. Magyar CE, Zhang Y, Holstein-Rathlou NH, McDonough AA. Proximal tubule Na transporter responses are the same during acute and chronic hypertension. Am J Physiol Renal Physiol 2000; 279:F358-F369.
36. Yip KP, Tse CM, McDonough AA, Marsh DJ. Redistribution of Na\+/H\+ exchanger isoform NHE3 in proximal tubules induced by acute and chronic hypertension. Am J Physiol 1998; 275 (4 Pt 2):F565-F575.
37. Papies B, Frille J, Gunther KH, Wagenknecht C. Isoenzyme (lactate dehydrogenase, aspartate aminotransferase) and dipeptidyl peptidase IV activity changes in blood plasma likely indicative of organ involvement due to arterial hypertension. Cor Vasa 1991; 33:218-226.
38. Nishikawa M, Itakura A, Ito M, Takeuchi M, Sato Y, Kajiyama H, et al. Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction. Horm Metab Res 2005; 37:408-413. (Pubitemid 41081219)
39. Linardi A, Panunto PC, Ferro ES, Hyslop S. Peptidase activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME). Biochem Pharmacol 2004; 68:205-214. (Pubitemid 38757689)
40. Lefebvre J, Murphey LJ, Hartert TV, Jiao Shan R, Simmons WH, Brown NJ. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension 2002; 39 (2 Pt 2):460-464. (Pubitemid 34165165)